David Miller, the pioneering CEO of FlowGardens, joined me for an interesting conversation recently. During the show, David eloquently explained his transition from finance into the burgeoning cannabinoid industry.
David described the challenges of operating in Tennessee’s complicated market and FlowGardens’ focus on developing unique cannabis genetics and alternative cannabinoids like CBC, THCV, and CBDV. He also emphasized the importance of educating consumers on the vast potential health benefits of these lesser-known compounds. For example, early studies showed promising anti-cancer and anti-inflammatory properties of CBG and CBC.
He explained the challenge of shifting consumer focus away from high THC strains alone towards more balanced, holistic medicinal options. Though Tennessee’s strict regulations present obstacles, David remains optimistic, highlighting the opportunities it provides for innovation. He even sees potential for interstate sales from FlowGardens despite restrictions.
While Tennessee’s governor has opposed cannabis in the past, David looks ahead with positivity. He sees an evolving landscape in the state, full of possibilities for his avant-garde company. It was a pleasure to listen to his perspective on nudging the industry forward in a restrictive environment.
Join Richard Zwicky weekly in discovering new insights into the business of the global cannabis and psychedelics industries. A successful entrepreneur & consultant who has built organizations in multiple industries across four continents, including one of the largest cannabis producers in Latin America, Richard has built teams from startup through to 500 people spread across over 10 countries, and regularly consults to businesses of all sizes with regards to their growth strategies, go-to-market plans, and paths to funding.
With insights drawn from multiple industries, Richard helps current and aspiring investors gain clarity of vision and insights into the drivers of growth and success in the cannabis and psychedelics industries in the US, and globally.Â
This engaging discussion with Richard Zwicky and Steven Murphy, CEO of Prohibition Partners, explores the dynamic world of the global cannabis industry, offering valuable insights into current trends, regulatory challenges, and emerging opportunities.
Steven and Richard analyze the current state of the cannabis industry, with a focus on Germany and North America. They discuss the influx of new players, the importance of patient acquisition, and the potential for industry consolidation. They also examine the progress of cannabis clubs and pilot programs in Germany, emphasizing the need for effective regulation and control in this evolving market. The conversation explores the potential for cannabis legalization in 2025, particularly in California, and the implications of interstate commerce. Steven provides insights from the upcoming Prohibition Partners global cannabis report, highlighting the European model as a potential gold standard for standardization and global trade. They also discuss the potential impact of the UN's rewording of drug schedules and the growth of cannabis markets in Brazil, Australia, and Poland.
Steven and Richard delve into the current state of the cannabis industry, focusing on cultivation and supply chain opportunities. They discuss the potential for Latin American and Asian countries to lead in quality production, the challenges of Canadian protectionism, and the importance of innovation and cost reduction. They also highlight the availability of distressed assets and the potential for global growth in the industry. The discussion highlights upcoming cannabis events in June, including European Cannabis Week, Cannabis Europa in London, and the Business of Cannabis Berlin event. Both Richard and Steven emphasize the importance of these events in facilitating industry connections and driving business development.
This insightful conversation provides a comprehensive overview of the global cannabis landscape, offering valuable perspectives on its future trajectory.